SCA features two state-of-the-art sterile compounding facilities which provide the ultimate environment for our team to prepare customized sterile pharmaceuticals for our customers.
Located in Little Rock, Arkansas, our 17,000-sq. ft. sterile compounding facility is composed of (2) extensive ISO 7 sterile compounding laboratories which contain a number of ISO 5 horizontal and vertical flow laminar hoods.
Our newest facility, which boasts 90,000-sq. ft. of production and office space, is located in Windsor, Connecticut. This facility features a full-scale GLP analytical chemistry lab, a high capacity aseptic production suite, cGMP cleanrooms and quality control laboratories.
These two facilities allow us to put significant teams and resources together across two locations to meet your needs and exceed expectations.
SCA exceeds USP <797> standards, and meets cGMP manufacturing guidelines. We also have backup generator power at each facility to ensure continual operations in the event of inclement weather or electrical failure.
SCA has obtained State Boards of Pharmacy licenses in all states, which allows us to provide outsourced medications to health systems across the country. SCA is a licensed DEA manufacturer and therefore abides by very stringent record keeping and security regulations. We are rapidly growing and will continue to expand our Windsor, Connecticut facility through 2018.
SCA Pharmaceuticals is committed to quality by design, compliance with regulatory guidelines, upholding the highest ethical standards in the industry, and ensuring that our clients receive the highest quality products and service possible.